These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2519544)

  • 21. Purging in BCR-ABL-positive acute lymphoblastic leukemia using immunomagnetic beads: comparison of residual leukemia and purging efficiency in bone marrow vs peripheral blood stem cells by semiquantitative polymerase chain reaction.
    Atta J; Fauth F; Keyser M; Petershofen E; Weber C; Lippok G; Hoelzer D; Martin H
    Bone Marrow Transplant; 2000 Jan; 25(1):97-104. PubMed ID: 10654022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of CD33 monoclonal antibodies in bone marrow transplantation for acute myeloid leukemia.
    Robertson MJ; Roy DC; Stone RM; Ritz J
    Prog Clin Biol Res; 1994; 389():47-63. PubMed ID: 7700916
    [No Abstract]   [Full Text] [Related]  

  • 23. Application of hypothermia to autologous stem cell purging.
    Miyagi K; Yamazaki T; Tsujino I; Takahashi N; Koya Y; Masutani M; Sawada U; Horie T
    Cryobiology; 2001 May; 42(3):190-5. PubMed ID: 11578118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peanut agglutinin purging and magnetic microspheres.
    Rhodes EG; Baker PK; Duguid JK; Cawley JC
    Prog Clin Biol Res; 1992; 377():139-46. PubMed ID: 1438410
    [No Abstract]   [Full Text] [Related]  

  • 25. 4-Hydroperoxycyclophosphamide purged autologous bone marrow transplantation of relapsed, responding non-Hodgkin's lymphoma with granulocyte colony stimulating factor support results in reliable hematopoietic recovery.
    Biggs D; Stadtmauer E; Mangan P; Edelstein M; Powlis W; Buzby G; Magee D; Sachs B; Silberstein L
    Prog Clin Biol Res; 1994; 389():9-15. PubMed ID: 7535466
    [No Abstract]   [Full Text] [Related]  

  • 26. [Ex vivo purging for autologous hemopoietic progenitor cell transplantation].
    Moriyama Y
    Rinsho Byori; 1995 Jul; Suppl 99():54-65. PubMed ID: 7474426
    [No Abstract]   [Full Text] [Related]  

  • 27. Autologous bone marrow transplantation for leukemia.
    Stuart RK
    Semin Oncol; 1993 Oct; 20(5 Suppl 6):40-54. PubMed ID: 8211215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Application of IHW2 purged bone marrow to autologous bone marrow transplantation in the treatment of acute myeloid leukemia].
    Jiang R; Han M; Zhao Y
    Zhonghua Xue Ye Xue Za Zhi; 1998 Jun; 19(6):312-4. PubMed ID: 11243113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the protection of murine bone marrow stem cells by WR-2721 during in vitro treatment with mafosfamide.
    Jiang R; Bony V; Lopez M
    Prog Clin Biol Res; 1994; 389():23-9. PubMed ID: 7700906
    [No Abstract]   [Full Text] [Related]  

  • 30. [Autologous BMT for B-lineage adult ALL patients using ex vivo purging with monoclonal antibodies].
    Mizuta S; Kawano A
    Rinsho Ketsueki; 1997 May; 38(5):422-5. PubMed ID: 9194387
    [No Abstract]   [Full Text] [Related]  

  • 31. New developments in stem cell detection and stem cell selection in the context of autologous transplantations.
    Douay L; Lopez M; Giarratana MC; Bony V; Bouchet S; Gorin NC
    Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):87-9. PubMed ID: 8099734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of ex vivo treatment with methylprednisolone and vincristine on bone marrow lymphohematopoietic cells.
    Kapoor N; Keever CA; Leong N; Beck EX
    Prog Clin Biol Res; 1992; 377():49-56. PubMed ID: 1438443
    [No Abstract]   [Full Text] [Related]  

  • 33. Autologous bone marrow transplantation for high risk acute lymphoblastic leukemia: clinical relevance of ex vivo bone marrow purging with monoclonal antibodies and complement.
    Grañena A; Castellsagué X; Badell I; Ferra C; Ortega J; Brunet S; Puntí C; Sureda A; Picón M; Valls A; Rutllant M; García J
    Bone Marrow Transplant; 1999 Sep; 24(6):621-7. PubMed ID: 10490727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Recent advances in the study of autologous hematopoietic stem cell purging].
    Wu SK; Lin C; Song ST
    Zhonghua Zhong Liu Za Zhi; 2005 Feb; 27(2):65-8. PubMed ID: 15946540
    [No Abstract]   [Full Text] [Related]  

  • 35. Use of gene marking in bone marrow transplantation.
    Heslop HE; Rooney CM; Rill DR; Krance RA; Brenner MK
    Cancer Detect Prev; 1996; 20(2):108-13. PubMed ID: 8706035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Autologous bone marrow transplantation in children with malignant diseases. Bone marrow harvest and procedure-related toxicity].
    Schrøder H; Clausen N; Thorling K; Hokland P
    Ugeskr Laeger; 1993 May; 155(20):1536-9. PubMed ID: 8316985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of immunotherapy in bone marrow transplantation for acute myeloid leukemia.
    Prentice HG; Macdonald ID; Hamon MD
    Prog Clin Biol Res; 1994; 389():239-43. PubMed ID: 7700907
    [No Abstract]   [Full Text] [Related]  

  • 38. T-cell depletion from allogeneic bone marrow by counterflow centrifugation is not associated with a substantial loss of CD34-positive cells.
    Preijers F; Ruijs P; Schattenberg A; de Witte T
    Prog Clin Biol Res; 1994; 389():339-44. PubMed ID: 7535440
    [No Abstract]   [Full Text] [Related]  

  • 39. The role and methodology for purging tumor from autologous bone marrow and peripheral blood progenitor cells.
    Purdy MH; Shpall EJ
    Med Oncol; 1994; 11(2):47-51. PubMed ID: 7531586
    [No Abstract]   [Full Text] [Related]  

  • 40. Autologous BMT in high risk patients with CALLA-positive ALL: possible efficacy of ex vivo marrow leukemia cell purging with monoclonal antibodies and complement.
    Morishima Y; Miyamura K; Kojima S; Ueda R; Morishita Y; Sao H; Tanimoto M; Ohno R; Sobue R; Hirano M
    Bone Marrow Transplant; 1993 Apr; 11(4):255-9. PubMed ID: 7683550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.